stars 1 stars 2 stars 3

At CHO Pharma, we believe the next breakthrough in medicine begins with a deeper understanding of biology. By harnessing the science of glycobiology and the precision of glycoengineering, we seek to transform biological insights into differentiated therapeutic solutions — to address unmet medical needs and make a meaningful difference for patients.

CHO Pharma Questions

The CHO Pharma annual revenue was $5.5 million in 2026.

CHO Pharma is based in Taipei, Taipei.

The NAICS codes for CHO Pharma are [3254, 32541, 32, 325].

The SIC codes for CHO Pharma are [283, 28].

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users